Management of cutaneous T-cell lymphomas: Established and emergent therapies

The Australasian Journal of Dermatology
Thevaki WainJillian Wells

Abstract

Cutaneous T-cell lymphoma is an uncommon group of non-Hodgkin's lymphoma primarily affecting the skin. It is comprised of a variety of entities with different clinical behaviours and prognosis. Mycosis fungoides is the commonest subtype, and Sézary syndrome is a much rarer form of cutaneous T-cell lymphoma. At this stage, control rather than cure is the goal of therapy, with particular emphasis placed on preserving quality of life. Our review of the efficacy, safety profile and accessibility of treatment modalities for mycosis fungoides/Sézary syndrome is a tailored guide for the clinician treating these rare conditions.

References

Sep 2, 1998·Archives of Dermatology·H S ZackheimS Amin
May 2, 2002·International Journal of Dermatology·Shirley Bassiri-TehraniDavid E Cohen
Oct 25, 2003·Journal of the American Academy of Dermatology·Peter HealdUNKNOWN Worldwide Bexarotene Study Group
Oct 25, 2003·Journal of the American Academy of Dermatology·Herschel S ZackheimAlex McMillan
Dec 23, 2003·Dermatologic Therapy·Herschel S Zackheim
Mar 23, 2004·Journal of the American Academy of Dermatology·Narin ApisarnthanaraxMadeleine Duvic
Feb 9, 2005·CNS Drugs·Charles L RaisonAndrew H Miller
Aug 11, 2006·Journal of the European Academy of Dermatology and Venereology : JEADV·G GökdemirA Köşlü
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elise A OlsenMadeleine Duvic
Dec 27, 2007·Cancer Biotherapy & Radiopharmaceuticals·Agustin AvilésJudith Huerta-Guzmán
Feb 6, 2008·Journal of the American Academy of Dermatology·Camille E IntrocasoAlain H Rook
Jul 29, 2008·Journal of the American Academy of Dermatology·Suzanne ArulogunChristopher McCormack
Jul 24, 2012·International Journal of Radiation Oncology, Biology, Physics·Tarita O ThomasBharat B Mittal
Sep 18, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Madeleine DuvicH Miles Prince
Jan 21, 2014·The British Journal of Dermatology·A de MassonM Bagot
Mar 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michinori OguraRyuzo Ueda
Sep 2, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·C KapserS Molin
Mar 31, 2015·Clinical Lymphoma, Myeloma & Leukemia·Silvia Alberti-ViolettiMadeleine Duvic
May 20, 2015·The Australasian Journal of Dermatology·Charlotte Fm HughesH Miles Prince
Jun 24, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Owen A O'ConnorAndrei Shustov
Jul 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Youn H KimSteven M Horwitz
Oct 5, 2015·Dermatologic Clinics·Auris O Huen, Ellen J Kim
Oct 5, 2015·Dermatologic Clinics·Gary S Wood, Jianqiang Wu
Oct 5, 2015·Dermatologic Clinics·Pooja VirmaniChristiane Querfeld
Jan 27, 2016·Critical Reviews in Oncology/hematology·Pier Luigi ZinzaniStefano Pileri
Jun 15, 2016·The Lancet Oncology·Anish ThomasRaffit Hassan
Sep 18, 2016·Clinical Lymphoma, Myeloma & Leukemia·Francine FossSean Whittaker
Apr 4, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Franz TrautingerRobert Knobler
Jan 9, 2018·Leukemia & Lymphoma·Jenna JanigaFarah Abdulla

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.